# H4C9

## Overview
H4C9 is a gene that encodes the H4 clustered histone 9 protein, a core histone protein integral to the structure of nucleosomes, which are the fundamental units of chromatin. As a histone protein, H4 clustered histone 9 plays a crucial role in the packaging of DNA within the nucleus, thereby influencing chromatin structure and gene regulation. This protein is involved in essential cellular processes such as DNA replication, repair, and transcription regulation, which are vital for maintaining genomic stability and proper cell cycle progression (Pires2023DNA). The H4C9 gene has been implicated in various biological contexts, including its potential role in viral carcinogenesis pathways and as a biomarker in certain cancers, such as hepatoblastoma (Vastrad2020Identification; Auwul2021Bioinformatics). Additionally, alterations in H4C9 expression and methylation patterns have been associated with clinical conditions like preeclampsia and osteosarcoma, highlighting its significance in both normal cellular function and disease states (Pires2023DNA; Norton2023Altered).

## Function
H4C9 encodes a histone protein, specifically histone H4, which is a core component of the nucleosome. Histones are essential for the packaging of DNA within the nucleus, facilitating the formation of chromatin structure and playing a critical role in gene regulation. The H4C9 gene is involved in several key molecular processes, including DNA replication, repair, and transcription regulation, which are vital for maintaining cell cycle progression and genomic stability (Pires2023DNA).

In the context of HIV infection, H4C9 and other replication-dependent core histone genes are modestly down-regulated, potentially due to the HIV-1 protein Vpr promoting cell cycle arrest. However, treatment with didehydro-cortistatin A (dCA) in combination with antiretroviral therapy (ART) can restore the expression of these genes to homeostatic levels, suggesting a role in modulating gene expression during HIV infection (Mori2024Transcriptional).

H4C9 is also mentioned in the context of the 'viral carcinogenesis' KEGG pathway, indicating its involvement in pathways related to infections and possibly cancer (Auwul2021Bioinformatics). However, specific details about its function in healthy human cells remain limited in the provided context.

## Clinical Significance
The H4C9 gene, which encodes a core histone protein involved in nucleosome formation and genome integrity, has been implicated in several clinical conditions. In the context of preeclampsia (PE), a pregnancy-related disorder, the H4C9 gene was found to be uniquely hypomethylated in placental tissues. This hypomethylation was associated with decreased levels of the H4 protein, potentially contributing to increased DNA damage observed in PE placentas. Although a direct connection between H4C9 and PE has not been established, the study suggests that reduced H4 protein levels might play a role in the pathophysiology of PE (Norton2023Altered).

In osteosarcoma, a type of bone cancer, the H4C9 gene is located in a region (6p22) that shows a high frequency of gains and losses, with the gene itself being hypomethylated. This suggests a potential involvement of H4C9 in the development of osteosarcoma, although the clinical significance of these alterations remains to be fully elucidated (Pires2023DNA). These findings highlight the importance of further research into the role of H4C9 in various diseases, particularly those involving epigenetic modifications.

## Interactions
H4C9, a gene encoding one of the histone H4 proteins, plays a significant role in chromatin structure and function. Histone H4 proteins, including H4C9, are integral components of nucleosomes, where they interact with DNA to form the basic unit of chromatin. These interactions are crucial for chromatin remodeling and influence gene expression and DNA repair processes. H4C9 is involved in forming multiprotein complexes with other histones, such as H2A, H2B, and H3, which are essential for maintaining nucleosome stability and chromatin integrity (Dubey2024Unraveling).

In the context of cancer, H4C9 has been identified as a potential novel diagnostic and prognostic biomarker in hepatoblastoma, suggesting its involvement in cellular processes related to cancer progression, such as metabolism, proliferation, and invasion (Vastrad2020Identification). Additionally, H4C9 is implicated in pathways related to viral carcinogenesis, indicating its potential interactions with other genes involved in these pathways (Auwul2021Bioinformatics).

H4C9's role in nucleosome organization and gene expression regulation is highlighted in studies examining cellular resistance processes, where it remains isolated in certain regulatory networks, suggesting specific interaction patterns that may distinguish sensitive and resistant cellular states (Arjmand2023Evaluation).


## References


[1. (Norton2023Altered) Carter Norton, Derek Clarke, Joshua Holmstrom, Isaac Stirland, Paul R. Reynolds, Tim G. Jenkins, and Juan A. Arroyo. Altered epigenetic profiles in the placenta of preeclamptic and intrauterine growth restriction patients. Cells, 12(8):1130, April 2023. URL: http://dx.doi.org/10.3390/cells12081130, doi:10.3390/cells12081130. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells12081130)

[2. (Auwul2021Bioinformatics) Md Rabiul Auwul, Md Rezanur Rahman, Esra Gov, Md Shahjaman, and Mohammad Ali Moni. Bioinformatics and machine learning approach identifies potential drug targets and pathways in covid-19. Briefings in Bioinformatics, April 2021. URL: http://dx.doi.org/10.1093/bib/bbab120, doi:10.1093/bib/bbab120. This article has 76 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/bib/bbab120)

[3. (Mori2024Transcriptional) Luisa P Mori, Michael J Corley, Andrew T McAuley, Alina Pang, Thomas Venables, Lishomwa C Ndhlovu, Matthew E Pipkin, and Susana T Valente. Transcriptional and methylation outcomes of didehydro-cortistatin a use in hiv-1–infected cd4+t cells. Life Science Alliance, 7(10):e202402653, August 2024. URL: http://dx.doi.org/10.26508/lsa.202402653, doi:10.26508/lsa.202402653. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.26508/lsa.202402653)

4. (Vastrad2020Identification) Identification of potential core genes in hepatoblastoma via bioinformatics analysis. This article has 1 citations.

[5. (Arjmand2023Evaluation) Babak Arjmand, Mostafa Rezaei Tavirani, Somayeh Jahani Sherafat, Mitra Rezaei, Masoumeh Farahani, and Majid Rezaei Tavirani. Evaluation of the cellular resistance process in treated cells via extracorporeal photopheresis. Journal of Lasers in Medical Sciences, 14:e46, October 2023. URL: http://dx.doi.org/10.34172/jlms.2023.46, doi:10.34172/jlms.2023.46. This article has 0 citations.](https://doi.org/10.34172/jlms.2023.46)

[6. (Pires2023DNA) Sara Ferreira Pires, Juliana Sobral de Barros, Silvia Souza da Costa, Marília de Oliveira Scliar, André Van Helvoort Lengert, Érica Boldrini, Sandra Regina Morini da Silva, Ljubica Tasic, Daniel Onofre Vidal, Ana Cristina Victorino Krepischi, and Mariana Maschietto. Dna methylation patterns suggest the involvement of dnmt3b and tet1 in osteosarcoma development. Molecular Genetics and Genomics, 298(3):721–733, April 2023. URL: http://dx.doi.org/10.1007/s00438-023-02010-8, doi:10.1007/s00438-023-02010-8. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00438-023-02010-8)

[7. (Dubey2024Unraveling) Sushil Kumar Dubey, Rashmi Dubey, and Mark Ellsworth Kleinman. Unraveling histone loss in aging and senescence. Cells, 13(4):320, February 2024. URL: http://dx.doi.org/10.3390/cells13040320, doi:10.3390/cells13040320. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells13040320)